Safety of Autologous Stem Cell Treatment for Traumatic Brain Injury in Children
Status:
Completed
Trial end date:
2009-10-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine if bone marrow progenitor cell (BMPC) autologous
transplantation in children after isolated traumatic brain injury is safe and will improve
functional outcome.
Phase:
Phase 1
Details
Lead Sponsor:
The University of Texas Health Science Center, Houston